3rd Quarter - Report

ARENTFOX SCHIFF LLP for EXACT SCIENCES CORPORATION

Period 3rd Quarter 2022 Filed Oct 18, 2022 Signed by Gerald L. Mitchell

Official filing
Firm
ARENTFOX SCHIFF LLP
Client
EXACT SCIENCES CORPORATION
Income
$40,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues pertaining to cancer screening H.R. 1946 and S. 1873 (Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021), all provisions H.R. 6000 (Cures 2.0 Act), all provisions S. 4348 (FDASLA Act of 2022), Title VIII, Subtitle C, regarding regulation of in vitro clinical tests H.R. 7667 (Food and Drug Amendments of 2022), all provisions

LobbyistCovered position, as disclosed
DAN RENBERG —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 7667 (117th), S. 4348 (117th), S. 1873 (117th), H.R. 1946 (117th), H.R. 6000 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.